Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - TOTAL CURRENT ASSETS
Total Current Assets ALNY - Alnylam Pharmaceuticals, Inc.
2.98 B
LAST VALUE
1.97%
2 YEAR CAGR
19.79%
5 YEAR CAGR
23.59%
10 YEAR CAGR